Primary Site >> Liver Cancer
Gene >> FEZF2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: NTP Toxicology and Carcinogenesis Studies of Tris(2-ethylhexyl)phosphate (CAS No. 78-42-2) In F344/N Rats and B6C3F1 Mice (Gavage Studies). PMID: 12748680 |
Ref: Two-dimensional electrophoresis map of the human hepatocellular carcinoma cell line, HCC-M, and identification of the separated proteins by mass spectrometry. PMID: 10870966 |
Ref: Proteome analysis of a human heptocellular carcinoma cell line, HCC-M: an update. PMID: 11545412 |
Ref: Proteome analysis of human liver tumor tissue by two-dimensional gel electrophoresis and matrix assisted laser desorption/ionization-mass spectrometry for identification of disease-related proteins. PMID: 12481271 |
Ref: Proteomic analysis of cholangiocarcinoma cell line. PMID: 15048994 Ref: Proteomic analysis of differential protein expression in a human hepatoma revertant cell line by using an improved two-dimensional electrophoresis procedure combined with matrix assisted laser desorption/ionization-time of flight-mass spectrometry. PMID: 15095460 |
Ref: The up-regulation of proteasome subunits and lysosomal proteases in hepatocellular carcinomas of the HBx gene knockin transgenic mice. PMID: 16317774 Ref: Enrichment of low molecular weight fraction of serum for MS analysis of peptides associated with hepatocellular carcinoma. PMID: 16586431 |
Ref: [Preparation and characterization of monoclonal antibody against human carboxylesterases-II]. PMID: 17286910 Ref: Protein profile of human hepatocarcinoma cell line SMMC-7721: identification and functional analysis. PMID: 17552011 Ref: Proteomic analysis of EZH2 downstream target proteins in hepatocellular carcinoma. PMID: 17676662 Ref: [Identification of a naturally presented MAGE-A3 epitope on the surface of HLE cell line by mass spectrometry]. PMID: 17688791 |
Ref: BlotGlycoABCTM, an integrated glycoblotting technique for rapid and large scale clinical glycomics. PMID: 17986439 Ref: Glycomic analysis of alpha-fetoprotein L3 in hepatoma cell lines and hepatocellular carcinoma patients. PMID: 18479159 Ref: Integrated peptide and glycan biomarker discovery using MALDI-TOF mass spectrometry. PMID: 19163537 |
Ref: Comparative proteomics and molecular mechanical analysis in CDA-II induced therapy of LCI-D20 hepatocellular carcinoma model. PMID: 18853186 Ref: [Histomorphology and proteomics analysis of human fetus liver]. PMID: 19203452 Ref: Effects of tetrazanbigen on the protein expression in human hepatocellular carcinoma cell line QGY-7701. PMID: 19513611 Ref: Lectin-based glycoproteomics to explore and analyze hepatocellular carcinoma-related glycoprotein markers. PMID: 19711376 Ref: Proteomic analysis of differentially expressed proteins in hepatitis B virus-related hepatocellular carcinoma tissues. PMID: 19715608 |
Ref: MALDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of boosting decision tree model for diagnosis of hepatocellular carcinoma. PMID: 20660326 Ref: Hepatocellular carcinoma-associated protein markers investigated by MALDI-TOF MS. PMID: 21472284 |
Ref: Identifying serum biomarkers for TACE therapy efficiency of hepatocellular carcinoma. PMID: 21196300 Ref: Proteomic identification of RhoA as a potential biomarker for proliferation and metastasis in hepatocellular carcinoma. PMID: 21475975 Ref: Identification of two portal vein tumor thrombosis associated proteins in hepatocellular carcinoma: protein disulfide-isomerase A6 and apolipoprotein A-I. PMID: 21649721 Ref: Metabolomics study of alcohol-induced liver injury and hepatocellular carcinoma xenografts in mice. PMID: 21763219 Ref: Proteomic identification of CIB1 as a potential diagnostic factor in hepatocellular carcinoma. PMID: 21857112 Ref: Tightly-bound to DNA proteins in rat experimental hepatomas and normal liver cells. PMID: 21956462 Ref: Up-regulation of 42 kDa tubulin alpha-6 chain fragment in well-differentiated hepatocellular carcinoma tissues from patients infected with hepatitis C virus. PMID: 21965743 |
Ref: Detection and identification of peroxiredoxin 3 as a biomarker in hepatocellular carcinoma by a proteomic approach. PMID: 22344546 Ref: Serum profiling based on fucosylated glycoproteins for differentiating between chronic hepatitis B and hepatocellular carcinoma. PMID: 22425980 Ref: Apoptosis induced by 1,3,6,7-tetrahydroxyxanthone in Hepatocellular carcinoma and proteomic analysis. PMID: 22610480 Ref: Development of human hepatocellular carcinoma cell-targeted protein cages. PMID: 22621213 Ref: Comparative serum proteomic analysis involving liver organ-specific metastasis-associated proteins of nasopharyngeal carcinoma. PMID: 22970016 Ref: GRP78 and GAL3, differentially regulated by lymph node homogenates, as potential biomarkers for lymph node metastasis in mouse hepatocellular carcinoma cells. PMID: 23205138 |
Ref: Selective isolation and analysis of glycoprotein fractions and their glycomes from hepatocellular carcinoma sera. PMID: 23436760 Ref: Surface grafted glycopolymer brushes to enhance selective adhesion of HepG2 cells. PMID: 23711662 Ref: Protein expression profiling of nuclear membrane protein reveals potential biomarker of human hepatocellular carcinoma. PMID: 23724895 Ref: Anti-metastatic and differential effects on protein expression of epigallocatechin-3-gallate in HCCLM6 hepatocellular carcinoma cells. PMID: 23863984 Ref: Serum peptidome patterns of hepatocellular carcinoma based on magnetic bead separation and mass spectrometry analysis. PMID: 23915185 Ref: Serum lipid profiling of patients with chronic hepatitis B, cirrhosis, and hepatocellular carcinoma by ultra fast LC/IT-TOF MS. PMID: 24228263 Ref: Profiling of hepatocellular carcinoma cell cycle regulating genes targeted by calycosin. PMID: 24455688 |
Ref: Proteomic-based analysis for identification of proteins involved in 5-fluorouracil resistance in hepatocellular carcinoma. PMID: 23530500 Ref: Aberrant fucosylation of glycosphingolipids in human hepatocellular carcinoma tissues. PMID: 23902602 Ref: Increased concentrations of apo A-I and apo A-II fragments in the serum of patients with hepatocellular carcinoma by magnetic beads-assisted MALDI-TOF mass spectrometry. PMID: 24343737 Ref: eRF3b, a biomarker for hepatocellular carcinoma, influences cell cycle and phosphoralation status of 4E-BP1. PMID: 24466059 Ref: Mass spectrometry-based serum peptide profiling in hepatocellular carcinoma with bone metastasis. PMID: 24659894 Ref: Novel proteomic biomarker panel for prediction of aggressive metastatic hepatocellular carcinoma relapse in surgically resectable patients. PMID: 24946162 Ref: Role of IFN-ks, IFN-ks related genes and the DEPDC5 gene in Hepatitis B virus-related liver disease. PMID: 25032264 Ref: Two polymorphisms of USF1 gene (-202G>A and -844C>T) may be associated with hepatocellular carcinoma susceptibility based on a case-control study in Chinese Han population. PMID: 25367853 |
Ref: Screening antitumor bioactive fraction from Sauromatum giganteum (Engl.) Cusimano & Hett and sensitive cell lines with the serum pharmacology method and identification by UPLC-TOF-MS. PMID: 25756649 Ref: Plasma lipidomic fingerprinting to distinguish among hepatitis C-related hepatocellular carcinoma, liver cirrhosis, and chronic hepatitis C using MALDI-TOF mass spectrometry: a pilot study. PMID: 25822433 Ref: Upregulation of energy metabolism-related, p53-target TIGAR and SCO2 in HuH-7 cells with p53 mutation by geranylgeranoic acid treatment. PMID: 26700591 |
Ref: Identification of Differential Protein Expression in Hepatocellular Carcinoma Induced Wistar Albino Rats by 2D Electrophoresis and MALDI-TOF-MS Analysis. PMID: 27069327 Ref: Cancer cell specific cytotoxic effect of Rhoeo discolor extracts and solvent fractions. PMID: 27235722 Ref: Multidrug Delivery Systems Based on Human Serum Albumin for Combination Therapy with Three Anticancer Agents. PMID: 27453125 |
Ref: Modification of p27 with O-linked N-acetylglucosamine regulates cell proliferation in hepatocellular carcinoma. PMID: 27175940 Ref: Metabolomic study of the intervention effects of Shuihonghuazi Formula, a Traditional Chinese Medicinal formulae, on hepatocellular carcinoma (HCC) rats using performance HPLC/ESI-TOF-MS. PMID: 28108381 Ref: A pilot study of salivary N-glycome in HBV-induced chronic hepatitis, cirrhosis, and hepatocellular carcinoma. PMID: 28389847 Ref: Genetic Polymorphism of Epidermal Growth Factor rs4444903 Influences Susceptibility to HCV-Related Liver Cirrhosis and Hepatocellular Carcinoma in a Chinese Han Population. PMID: 28397482 Ref: Differential Proteomic Analysis of Gender-dependent Hepatic Tumorigenesis in Hras12V Transgenic Mice. PMID: 28512230 Ref: Comparative Analysis for Glycopatterns and Complex-Type N-Glycans of Glycoprotein in Sera from Chronic Hepatitis B- and C-Infected Patients. PMID: 28871230 Ref: Intracellular Drug Uptake-A Comparison of Single Cell Measurements Using ToF-SIMS Imaging and Quantification from Cell Populations with LC/MS/MS. PMID: 29039651 Ref: Ratiometric Mass Spectrometry for Cell Identification and Quantitation Using Intracellular "Dual-Biomarkers". PMID: 29234137 |
Ref: ITIH4: Effective Serum Marker, Early Warning and Diagnosis, Hepatocellular Carcinoma. PMID: 28828637 Ref: HCC Specific Protein Network Involving Interactions of EGFR with A-Raf and Transthyretin: Experimental Analysis and Computational Biology Correlates. PMID: 29732980 Ref: Proteomic Investigation to Identify Anticancer Targets of Nemopilema nomurai Jellyfish Venom in Human Hepatocarcinoma HepG2 Cells. PMID: 29748501 Ref: Purification, characterization and fine sugar specificity of a N-Acetylgalactosamine specific lectin from Adenia hondala. PMID: 30306293 Ref: Elevated expression of A-Raf and FA2H in hepatocellular carcinoma is associated with lipid metabolism dysregulation and cancer progression. PMID: 30324893 |